Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 38

1.

Antidepressant-Like Effects of Low- and High-Molecular Weight FGF-2 on Chronic Unpredictable Mild Stress Mice.

Wang L, Li XX, Chen X, Qin XY, Kardami E, Cheng Y.

Front Mol Neurosci. 2018 Oct 12;11:377. doi: 10.3389/fnmol.2018.00377. eCollection 2018.

2.

Fibroblast growth factor 2 is necessary for the antidepressant effects of fluoxetine.

Simard S, Shail P, MacGregor J, El Sayed M, Duman RS, Vaccarino FM, Salmaso N.

PLoS One. 2018 Oct 1;13(10):e0204980. doi: 10.1371/journal.pone.0204980. eCollection 2018.

3.

Fibroblast Growth Factor 2 Modulates Hippocampal Microglia Activation in a Neuroinflammation Induced Model of Depression.

Tang MM, Lin WJ, Pan YQ, Li YC.

Front Cell Neurosci. 2018 Aug 8;12:255. doi: 10.3389/fncel.2018.00255. eCollection 2018.

4.

Cell encapsulation enhances antidepressant effect of the mesenchymal stem cells and counteracts depressive-like behavior of treatment-resistant depressed rats.

Kin K, Yasuhara T, Kameda M, Tomita Y, Umakoshi M, Kuwahara K, Kin I, Kidani N, Morimoto J, Okazaki M, Sasaki T, Tajiri N, Borlongan CV, Date I.

Mol Psychiatry. 2018 Aug 14. doi: 10.1038/s41380-018-0208-0. [Epub ahead of print]

PMID:
30108315
5.

Connective Tissue Growth Factor Is a Novel Prodepressant.

Turner CA, Sharma V, Hagenauer MH, Chaudhury S, O'Connor AM, Hebda-Bauer EK, Thompson RC, Myers RM, Bunney WE, Barchas JD, Lee FS, Schatzberg AF, Watson SJ Jr, Akil H.

Biol Psychiatry. 2018 Oct 15;84(8):555-562. doi: 10.1016/j.biopsych.2018.04.013. Epub 2018 May 3.

6.

Fibroblast growth factor 2 regulates activity and gene expression of human post-mitotic excitatory neurons.

Gupta S, M-Redmond T, Meng F, Tidball A, Akil H, Watson S, Parent JM, Uhler M.

J Neurochem. 2018 May;145(3):188-203. doi: 10.1111/jnc.14255. Epub 2017 Dec 27.

7.

Saikosaponin-d-mediated downregulation of neurogenesis results in cognitive dysfunction by inhibiting Akt/Foxg-1 pathway in mice.

Lixing X, Zhouye J, Liting G, Ruyi Z, Rong Q, Shiping M.

Toxicol Lett. 2018 Mar 1;284:79-85. doi: 10.1016/j.toxlet.2017.11.009. Epub 2017 Nov 10.

PMID:
29129800
8.

Neurotrophins and neuroinflammation in fetuses exposed to maternal depression and anxiety disorders during pregnancy: a comparative study on cord blood.

Akbaba N, Annagür BB, Annagür A, Akbulut H, Akyürek F, Çelık Ç.

Arch Womens Ment Health. 2018 Feb;21(1):105-111. doi: 10.1007/s00737-017-0774-1. Epub 2017 Sep 7.

PMID:
28884439
9.

Antidepressant effect of taurine in chronic unpredictable mild stress-induced depressive rats.

Wu GF, Ren S, Tang RY, Xu C, Zhou JQ, Lin SM, Feng Y, Yang QH, Hu JM, Yang JC.

Sci Rep. 2017 Jul 10;7(1):4989. doi: 10.1038/s41598-017-05051-3.

10.

Exogenous FGF2 reverses depressive-like behaviors and restores the suppressed FGF2-ERK1/2 signaling and the impaired hippocampal neurogenesis induced by neuroinflammation.

Tang MM, Lin WJ, Zhang JT, Zhao YW, Li YC.

Brain Behav Immun. 2017 Nov;66:322-331. doi: 10.1016/j.bbi.2017.05.013. Epub 2017 May 18.

PMID:
28529071
11.

Altered peripheral immune profiles in treatment-resistant depression: response to ketamine and prediction of treatment outcome.

Kiraly DD, Horn SR, Van Dam NT, Costi S, Schwartz J, Kim-Schulze S, Patel M, Hodes GE, Russo SJ, Merad M, Iosifescu DV, Charney DS, Murrough JW.

Transl Psychiatry. 2017 Mar 21;7(3):e1065. doi: 10.1038/tp.2017.31.

12.

Selectively Bred Rats Provide a Unique Model of Vulnerability to PTSD-Like Behavior and Respond Differentially to FGF2 Augmentation Early in Life.

Prater KE, Aurbach EL, Larcinese HK, Smith TN, Turner CA, Blandino P Jr, Watson SJ, Maren S, Akil H.

Neuropsychopharmacology. 2017 Jul;42(8):1706-1714. doi: 10.1038/npp.2017.37. Epub 2017 Feb 16.

13.

Anxiolytic effects of muscarinic acetylcholine receptors agonist oxotremorine in chronically stressed rats and related changes in BDNF and FGF2 levels in the hippocampus and prefrontal cortex.

Di Liberto V, Frinchi M, Verdi V, Vitale A, Plescia F, Cannizzaro C, Massenti MF, Belluardo N, Mudò G.

Psychopharmacology (Berl). 2017 Feb;234(4):559-573. doi: 10.1007/s00213-016-4498-0. Epub 2016 Dec 12.

PMID:
27957715
14.

MPP+-Lesioned Mice: an Experimental Model of Motor, Emotional, Memory/Learning, and Striatal Neurochemical Dysfunctions.

Cunha MP, Pazini FL, Lieberknecht V, Budni J, Oliveira Á, Rosa JM, Mancini G, Mazzardo L, Colla AR, Leite MC, Santos ARS, Martins DF, de Bem AF, Gonçalves CAS, Farina M, Rodrigues ALS.

Mol Neurobiol. 2017 Oct;54(8):6356-6377. doi: 10.1007/s12035-016-0147-1. Epub 2016 Oct 8.

PMID:
27722926
15.

Significantly higher peripheral fibroblast growth factor-2 levels in patients with major depressive disorder: A preliminary meta-analysis under MOOSE guidelines.

Wu CK, Tseng PT, Chen YW, Tu KY, Lin PY.

Medicine (Baltimore). 2016 Aug;95(33):e4563. doi: 10.1097/MD.0000000000004563.

16.

FGFR1-5-HT1A Heteroreceptor Complexes: Implications for Understanding and Treating Major Depression.

Borroto-Escuela DO, Tarakanov AO, Fuxe K.

Trends Neurosci. 2016 Jan;39(1):5-15. doi: 10.1016/j.tins.2015.11.003. Epub 2015 Dec 12. Review.

PMID:
26687454
17.

Genetic and Stress-Induced Loss of NG2 Glia Triggers Emergence of Depressive-like Behaviors through Reduced Secretion of FGF2.

Birey F, Kloc M, Chavali M, Hussein I, Wilson M, Christoffel DJ, Chen T, Frohman MA, Robinson JK, Russo SJ, Maffei A, Aguirre A.

Neuron. 2015 Dec 2;88(5):941-956. doi: 10.1016/j.neuron.2015.10.046. Epub 2015 Nov 20.

18.

Deconstructing the Iboga Alkaloid Skeleton: Potentiation of FGF2-induced Glial Cell Line-Derived Neurotrophic Factor Release by a Novel Compound.

Gassaway MM, Jacques TL, Kruegel AC, Karpowicz RJ Jr, Li X, Li S, Myer Y, Sames D.

ACS Chem Biol. 2016 Jan 15;11(1):77-87. doi: 10.1021/acschembio.5b00678. Epub 2015 Oct 30.

PMID:
26517751
19.

Fibroblast growth factor 9 is a novel modulator of negative affect.

Aurbach EL, Inui EG, Turner CA, Hagenauer MH, Prater KE, Li JZ, Absher D, Shah N, Blandino P Jr, Bunney WE, Myers RM, Barchas JD, Schatzberg AF, Watson SJ Jr, Akil H.

Proc Natl Acad Sci U S A. 2015 Sep 22;112(38):11953-8. doi: 10.1073/pnas.1510456112. Epub 2015 Sep 8.

20.

Tricyclic Antidepressant Amitriptyline-induced Glial Cell Line-derived Neurotrophic Factor Production Involves Pertussis Toxin-sensitive Gαi/o Activation in Astroglial Cells.

Hisaoka-Nakashima K, Miyano K, Matsumoto C, Kajitani N, Abe H, Okada-Tsuchioka M, Yokoyama A, Uezono Y, Morioka N, Nakata Y, Takebayashi M.

J Biol Chem. 2015 May 29;290(22):13678-91. doi: 10.1074/jbc.M114.622415. Epub 2015 Apr 13.

Supplemental Content

Loading ...
Support Center